Back
Genmab AS Vs. Galecto Industry Stock Comparison
Sell
17
GNMSF
Genmab AS
Last Price:
202.36
Seasonality Move:
-0.77%
Sell
17
GLTO
Galecto
Last Price:
5.98
Seasonality Move:
-0.96%
Sell
17
Genmab AS (GNMSF)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
- The current Genmab AS [GNMSF] share price is $202.48. The Score for GNMSF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- GNMSF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
17
Galecto (GLTO)
is a Sell
Is Galecto a Buy, Sell or Hold?
- The current Galecto [GLTO] share price is $5.81. The Score for GLTO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- GLTO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GNMSF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.08 | Sell |
Relative Strength Index (14 RSI): | 35.52 | Sell |
Chaikin Money Flow: | -365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (213.7 - 229.94) | Sell |
Bollinger Bands (100): | (228.63 - 270.99) | Sell |
GLTO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.53 | Sell |
Relative Strength Index (14 RSI): | 25.82 | Sell |
Chaikin Money Flow: | -1903 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.44 - 7.26) | Sell |
Bollinger Bands (100): | (0.83 - 10.43) | Buy |
GNMSF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 215.66 | Sell |
20-day SMA: | 221.05 | Sell |
50-day SMA: | 233.37 | Sell |
200-day SMA: | 267.15 | Sell |
8-day EMA: | 212.26 | Sell |
20-day EMA: | 219.79 | Sell |
50-day EMA: | 232.09 | Sell |
200-day EMA: | 266.24 | Sell |
GLTO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.5 | Sell |
20-day SMA: | 6.84 | Sell |
50-day SMA: | 8.95 | Sell |
200-day SMA: | 3.15 | Buy |
8-day EMA: | 6.34 | Sell |
20-day EMA: | 6.85 | Sell |
50-day EMA: | 7.18 | Sell |
200-day EMA: | 4.34 | Buy |
Genmab AS Earnings Growth & GNMSF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Galecto Earnings Growth & GLTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.91 per share, and a decrease next year of $0.44 per share.
Genmab AS Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Galecto Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |